Since its first trial in 2019, Israel’s Active Implants (see here previously) has performed nearly 1,000 implants of its NUsurface synthetic meniscus in Israel and Europe. It expects FDA approval to allow launch in the US in 2024.
https://www.youtube.com/watch?v=tB8aWsXbGhg
https://www.israel21c.org/new-hope-for-people-who-kneed-a-new-meniscus/